PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
PCI Biotech: Successful Phase I fimaVACC vaccination proof of concept study to be published in Frontiers in Immunology
Guest UserNovember 23, 2020
PCI Biotech: European patent for treatment of bile duct cancer with the fimaCHEM technology
Guest UserNovember 16, 2020
PCI Biotech third quarter 2020 results
Guest UserNovember 11, 2020
PCI Biotech: Invitation to third quarter 2020 results presentation
Guest UserNovember 4, 2020
First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
Guest UserOctober 26, 2020
PCI Biotech: Preclinical research collaboration with big pharma ended
Guest UserOctober 21, 2020
Job Advertisement: Clinical Project Director
Guest UserOctober 6, 2020
PCI Biotech: Employee share option scheme
Guest UserOctober 6, 2020
PCI Biotech: Capital increase registered and listing of new shares
Guest UserSeptember 8, 2020
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
Guest UserSeptember 3, 2020
PCI Biotech announce a research collaboration with DCprime to explore novel cancer vaccination concepts
Guest UserSeptember 1, 2020
First half-year 2020 results
Guest UserAugust 26, 2020
PCI Biotech: Invitation to second quarter and first half 2020 results presentation
Guest UserAugust 19, 2020
PCI Biotech: Publication of case report series from the Phase I study in bile duct cancer
Guest UserAugust 19, 2020
PCI Biotech: Update on the preclinical research collaboration agreement with AstraZeneca
Guest UserJuly 13, 2020
Minutes from Annual General Meeting 2020
Morten LuhrMay 27, 2020
Disclosure of voting rights for Chairman of the Board
Morten LuhrMay 26, 2020
Notice of Annual General Meeting 2020
Morten LuhrMay 6, 2020
First quarter 2020 results
Morten LuhrMay 6, 2020
PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
NewsRonny SkuggedalMarch 31, 2020
Older

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED